Evidence map›Paper›PMID 29044109›Full record

ArticleNature communications2017

APOBEC3H structure reveals an unusual mechanism of interaction with duplex RNA.

Jennifer A Bohn, Keyur Thummar, Ashley York, Alice Raymond, W Clay Brown, Paul D Bieniasz, Theodora Hatziioannou, Janet L Smith

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Interactions of APOBEC3s with DNA and RNA.Current opinion in structural biology · 2021
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jennifer A BohnLife Sciences Institute, University of Michigan, Ann Arbor, MI, 48109, USA.
Keyur ThummarLaboratory of Retrovirology, The Rockefeller University, New York, NY, 10065, USA.ORCID http://orcid.org/0000-0003-3430-235X
Ashley YorkLaboratory of Retrovirology, The Rockefeller University, New York, NY, 10065, USA.
Alice RaymondLaboratory of Retrovirology, The Rockefeller University, New York, NY, 10065, USA.
W Clay BrownLife Sciences Institute, University of Michigan, Ann Arbor, MI, 48109, USA.
Paul D BieniaszLaboratory of Retrovirology, The Rockefeller University, New York, NY, 10065, USA.
Theodora HatziioannouLaboratory of Retrovirology, The Rockefeller University, New York, NY, 10065, USA. thatziio@rockefeller.edu.
Janet L SmithLife Sciences Institute, University of Michigan, Ann Arbor, MI, 48109, USA. JanetSmith@umich.edu.
Howard Hughes Medical Institute · USUniversity of Michigan · USRockefeller University · US

Funding

The Center for HIV RNA Studies (CRNA)P50GM103297 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TELESNITSKY, ALICE · 2012 to 2016
$21.7M
Overcoming Host Restriction Factors to Develop Better Animal Models for HIV/AIDS.R01AI078788 · NIAID · ROCKEFELLER UNIVERSITY · PI HATZIIOANNOU, THEODORA · 2008 to 2021
$9.3M
Cellular Biotechnology Training Program (CBTP)T32GM008353 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCHWENDEMAN, ANNA · 1991 to 2021
$9.3M
RNA Protein interactions in HIV-1 replicationR01AI050111 · NIAID · ROCKEFELLER UNIVERSITY · PI BIENIASZ, PAUL D. · 2001 to 2021
$7.9M
Cellular Biotechnology Training Program (CBTP) - Years 31-35T32GM145304 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Guizhi Zhu · 2022 to 2026
$2.6M
High-Speed High-Sensitivity Detector for X-ray Micro-Crystallography at GM/CA@APSS10OD012289 · OD · UNIVERSITY OF CHICAGO · PI FISCHETTI, ROBERT F. · 2014 to 2014
$2.0M
Silicon Mechanics Compute ClusterS10OD020011 · OD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SKINIOTIS, GEORGIOS · 2015 to 2015
$490k
Characterization of retroviral restriction factor APOBEC3HF31AI129697 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BOHN, JENNIFER · 2017 to 2018
$72k
Howard Hughes Medical InstituteNIAID NIH HHS F31 AI129697NIAID NIH HHS R01 AI050111NIAID NIH HHS R01 AI078788NIGMS NIH HHS P50 GM103297NIGMS NIH HHS T32 GM008353NIGMS NIH HHS T32 GM145304NIH HHS S10 OD012289NIH HHS S10 OD020011
6 · The paper itself

Abstract

The APOBEC3 family of cytidine deaminases cause lethal hypermutation of retroviruses via deamination of newly reverse-transcribed viral DNA. Their ability to bind RNA is essential for virion infiltration and antiviral activity, yet the mechanisms of viral RNA recognition are unknown. By screening naturally occurring, polymorphic, non-human primate APOBEC3H variants for biological and crystallization properties, we obtained a 2.24-Å crystal structure of pig-tailed macaque APOBEC3H with bound RNA. Here, we report that APOBEC3H forms a dimer around a short RNA duplex and, despite the bound RNA, has potent cytidine deaminase activity. The structure reveals an unusual RNA-binding mode in which two APOBEC3H molecules at opposite ends of a seven-base-pair duplex interact extensively with both RNA strands, but form no protein-protein contacts. CLIP-seq analysis revealed that APOBEC3H preferentially binds to sequences in the viral genome predicted to contain duplexes, a property that may facilitate both virion incorporation and catalytic activity.

Indexed as

Nucleic Acid ConformationProtein DomainsAminohydrolasesAnimalsCrystallography, X-RayCytidine DeaminaseHEK293 CellsHumansMacaca nemestrinaModels, MolecularProtein BindingRNAAminohydrolasesCytidine DeaminaseRNA

Identifiers

PMID29044109
PMCPMC5647330
OpenAlexW2761325172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.